St. Jude Children's Research Hospital
489
101
159
271
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
8.6%
42 terminated/withdrawn out of 489 trials
86.6%
-0.0% vs industry average
5%
24 trials in Phase 3/4
34%
92 of 271 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (489)
Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer
Role: lead
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
Role: lead
A Registry of Cases of Spinal Muscular Atrophy
Role: lead
Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE
Role: lead
Cognitive Rehabilitation for Survivors of Childhood Medulloblastoma Using Real Time Hemodynamic Neurofeedback
Role: lead
Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma
Role: lead
Using Bioimpedance Analysis to Monitor Fluid Status in Children
Role: lead
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
Role: lead
Therapy for Children With Advanced Stage Neuroblastoma
Role: lead
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
Role: lead
Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
Role: lead
Liver Biopsy Following Gene Therapy For Hemophilia
Role: lead
Real World Asparaginase Therapy Toxicity
Role: lead
Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)
Role: lead
Haploidentical HCT for Severe Aplastic Anemia
Role: lead
Muscle Aging Phenotypes in Childhood Cancer Survivors
Role: lead
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
Role: lead
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
Role: lead
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Role: lead
Long Term Follow-Up Study for Individuals With Hemoglobin Disorders After Hematopoietic Cell Transplant or Gene Therapy
Role: lead